Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F. Grace, Bertil Glader, Eduard J. van Beers et al.|New England Journal of Medicine|2019Cited by 162
Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK StudyRachael F. Grace, Bertil Glader, Christian Rosé et al.|Blood|2016Cited by 6
Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase DeficiencyRachael F. Grace, Bertil Glader, D. Mark Layton et al.|Blood|2017Cited by 2